Citations 2
S5 Sustained Improvements in Health-Related Quality of Life Outcomes With Long-Term Risankizumab Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Results from the FORTIFY Open-Label, Long-Term Extension
Joshi, Namita , Griffith, Jenny, Song, Alexandra , Kim, Brooke, Platt, Andrew M. , Louis, Édouard , Loftus, Edward V. , Peyrin‐Biroulet, Laurent , Ghosh, Subrata , Shukla, Nidhi , Louis, Edouard
American Journal of Gastroenterology | December 9, 2024 | Volume: 119 | Issue: 12S | Pages: S2-S2
S7 Efficacy of Upadacitinib in Patients With One or More Prior Surgical Procedures for Crohn’s Disease: A Post Hoc Analysis of U-EXCEL, U-EXCEED, and U-ENDURE Phase 3 Trials
Lakatos, Péter L. , Lacerda, Ana P. , Kim, Brooke, Liu, John , Anyanwu, Samuel, Kligys, Kristina, Garrison, Andrew, Lichtenstein, Gary R. , Lakatos, Peter L , Loftus, Edward V. , Regueiro, Miguel , Sands, Bruce E , Magro, Fernando , Raine, Tim
American Journal of Gastroenterology | December 14, 2023 | Volume: 118 | Issue: 12S | Pages: S3-S3